In a filing, Viking Therapeutics Inc revealed its Chief Financial Officer ZANTE GREG unloaded Company’s shares for reported $4.99 million on May 03 ’24. In the deal valued at $74.69 per share,66,756 shares were sold. As a result of this transaction, ZANTE GREG now holds 174,854 shares worth roughly $13.68 million.
Then, Mancini Marianna sold 281,425 shares, generating $22,136,474 in total proceeds. Upon selling the shares at $78.66, the Chief Operating Officer now owns 348,508 shares.
Before that, Lian Brian sold 45,000 shares. Viking Therapeutics Inc shares valued at $1,345,500 were divested by the President & CEO at a price of $29.90 per share. As a result of the transaction, Lian Brian now holds 2,139,882 shares, worth roughly $167.36 million.
Oppenheimer reiterated its Viking Therapeutics Inc [VKTX] rating to an Outperform in a research note published on March 26, 2024; the price target was $138. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early March with a ‘”a Buy”‘ rating. Oppenheimer also remained covering VKTX and reiterated its “an Outperform” recommendation on February 28, 2024.
Price Performance Review of VKTX
On Monday, Viking Therapeutics Inc [NASDAQ:VKTX] saw its stock jump 1.61% to $78.21. Over the last five days, the stock has gained 3.70%. Viking Therapeutics Inc shares have risen nearly 320.26% since the year began. Nevertheless, the stocks have risen 260.91% over the past one year. While a 52-week high of $99.41 was reached on 02/28/24, a 52-week low of $8.28 was recorded on 01/03/24. SMA at 50 days reached $73.12, while 200 days put it at $30.55. A total of 3.07 million shares were traded, compared to the trading of 2.15 million shares in the previous session.
Levels Of Support And Resistance For VKTX Stock
The 24-hour chart illustrates a support level at 74.64, which if violated will result in even more drops to 71.07. On the upside, there is a resistance level at 80.83. A further resistance level may holdings at 83.45. The Relative Strength Index (RSI) on the 14-day chart is 61.07, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 5.98, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 11.57%. Stochastics %K at 81.86% indicates the stock is a selling.
The most recent change occurred on March 28, 2023 when Maxim Group resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $25.
